Resmed Inc Q3 FY2026 Earnings Call

Resmed Inc (RMD)

Earnings Call FY2026 Q3 Call date: 2026-04-30 Concluded

Quarter scorecard

Revenue

$1.43B

+10.8% YoY

Diluted EPS

$2.74

+10.5% YoY

Gross margin

62.2%

+2.9 pp YoY

Net income

$398.73M

+9.2% YoY

Sleep and Breathing Health $1.26B

+11.5%

Residential Care Software $170.89M

+6%

Buybacks (derived)

$175.01M

Dividend / share

$0.60

ex May 14